217O Pembrolizumab (pembro) combination therapies in patients with metastatic castration-resistant prostate cancer (mCRPC): Cohorts A-C of the phase Ib/II KEYNOTE-365 study

Authors :: Josep M. Piulats
Henry Jacob Conter
Howard Gurney
Srikala S. Sridhar
William R. Berry
Evan Y. Yu
Michael Paul Kolinsky
Emanuela Romano
Charles Schloss
N.D. Shore
Haiyan Wu
Marinela Augustin
Christian Heinrich Poehlein
Margitta Retz
Peter C.C. Fong
Leonard Joseph Appleman
Anthony M. Joshua
Tilman Todenhöfer
Ali Tafreshi
J.S. de Bono
Source :: Annals of Oncology. 31:S1325
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Prostate cancer
business.industry
Internal medicine
Medicine
In patient
Hematology
Pembrolizumab
Castration resistant
business
medicine.disease

Tools